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Abstract
Worldwide, invasive pneumococcal disease caused by Streptococcus pneumoniae is most common in young children. In
adults, disease rates decline following intermittent colonization and the acquisition of naturally acquired immunity. We
characterized mucosal and systemic pneumococcal-specific T-cell responses in African children and adults who contend
with intense rates of colonization, up to 100% and 60% respectively. We find most Malawian children have high
pneumococcal-specific T-cell responses in tonsil tissue and peripheral blood. In addition, frequent commensalism generates
CD25hi (Tregs) which modulate mucosal pneumococcal-specific T-cell responses in some children and $50% of adults. We
propose that immune regulation may prolong pneumococcal colonization and predispose vulnerable individuals to disease.
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Introduction
In sub-Saharan Africa and elsewhere, invasive pneumococcal
disease (IPD) is most common in young children, the elderly and
immunocompromised [1]. In healthy adults, pneumococcal
colonisation and disease declines due to the acquisition of naturally
acquired immunity, generated by carriage of the pneumococcus in
the nasopharynx [2,3]. Limiting pneumococcal carriage at the
mucosa, due to vaccination, is thought to reduce invasion and
result in herd immunity by blocking person-to-person spread, thus
protecting those who remain immunologically susceptible.
The immune processes that control colonization and invasion
are not well understood. Natural immunity to the pneumococcus
was thought to be largely mediated by antibodies to the
polysaccharide capsule [2]. However, more recently, animal
models and studies of human carriage have implicated a range
of sub-capsular protein antigens in protection against both nasal
colonization and invasive disease [3]. Furthermore, pneumococcal
carriage experiments comparing antibody-deficient with T cell-
deficient mice suggest that CD4 T-cells are key to the mucosal
clearance of S. pneumoniae and that antibodies to pneumococcal
antigens correlate with, but may not be required for protection
against colonization [4]. In healthy Gambian adults, we found
high numbers of effector and central memory CD4 T-cells to
pneumococcal antigens in blood [5] and have demonstrated in
Malawian adults that the lung mucosal surface is dominated by
pneumococcal-specific memory CD4+CD45RA2CCR72effector
cells [6]. More recently in a low carriage intensity UK population,
we described an age related acquisition of mucosal T cell-mediated
pneumococcal immunity in the nasopharynx, the site of immune
induction [7].
We have proposed that in many African populations, suscep-
tibility to IPD is considerably amplified by mucosal immune
dysregulation, mediated by environmental, nutritional and micro-
bial pressures including measles, malaria and HIV [8]. In several
developing countries, pneumococcal carriage occurs very early in
life, reaching up to 100% in children and 60% in adults [9], far
exceeding industrialized countries. The impact of intense coloni-
zation on the development of natural immunity in this setting is
unknown. Recently, we have shown that antigen-specific CD25hi
cells regulate mucosal pneumococcal-specific responses in adults in
a UK setting of low carriage intensity [7]. As pneumococcal
colonization generates low-level inflammation, immune regulation
can limit mucosal damage but inadvertently suppress immunity
and prolong bacterial colonization. We hypothesize that in sub-
Saharan Africa high levels of carriage leads to the generation of
large numbers of pneumococcal-specific CD4 T-cells which are
then rapidly controlled by localised regulatory T-cells (Treg).
Over-regulation may hinder naturally acquired immunity and
increase IPD in susceptible individuals.
To address this possibility, we have investigated the acquisition
of pneumococcal-specific immunity in the mucosal palatine tonsils
and the recirculation of CD4 T-cells in the blood of Malawian
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children and adults. We also evaluated whether T regs were
generated following natural exposure.
Materials and Methods
Ethics Statement
The collection of samples and the research performed was
undertaken in accordance with institutional guidelines and
approved by the University of Malawi College of Medicine Ethics
Committee (P.03/10/919) and The Liverpool School of Tropical
Medicine Research Ethics Committee (10.60). A total of forty
Malawian children and adults were recruited into the study
following informed consent.
Subjects
Palatine tonsils and blood samples were obtained from healthy
individuals (aged 1–39 years) undergoing routine tonsillectomy for
recurrent tonsillitis or upper airway obstruction at Queen
Elizabeth Central Hospital, Mwaiwathu and Seventh Day
Adventist Hospitals in Blantyre, Malawi. Tonsils were collected
into RPMI media (Invitrogen, Paisley, UK,) supplemented with
100 U/ml penicillin, 100 mg/ml streptomycin (Sigma, Dorset,
UK) and blood samples into sodium heparin tubes. Patients with
HIV or serious infections were excluded from the study. Due to
limited volumes of blood obtained from some subjects, not all
assays were performed on every subject.
Antigens
Pneumococcal culture supernatants (pneumoCCS) were pre-
pared from a standard encapsulated type 2 (D39) S pneumoniae
strain and an isogenic pneumolysin-deficient mutant (Ply-). Bio-
Rad protein assay was used to measure the concentration of
pneumoCCS. The culture supernatants were heat inactivated at
56uC for 30 min to reduce toxic effects of pneumococcal proteins.
M. tuberculosis (MTB) purified protein derivative (PPD RT49) was
obtained from Statens Serum Institut, Denmark. Influenza
antigens were derived from dialyzed inactive trivalent split virion
influenza vaccine (EnziraH 2006/2007) obtained from Aventis-
Pasteur, France.
Cells and Reagents
Blood and tonsil tissue mononuclear cells (MNC) were isolated
by histopaque density gradient separation [10,11]. MNC were
harvested, washed in HBSS at 400 g for 10 min, and resuspended
in complete RPMI (RPMI 1640 with 100 U/ml penicillin,
0.1 mg/ml streptomycin, 4 mM L-glutamine, and 10 mM HEPES
buffer). MNC were counted using 0.4% (wt/vol) trypan blue
(Sigma), reconstituted in complete RPMI at a concentration of
16106 cells/ml; with a final concentration of 2% (vol/vol) heat-
inactivated human AB serum (National Blood Services, Blantyre)
and incubated at 37uC in presence of 5% CO2.
Tonsillar MNC CD25hi Cell Depletion
CD25hi cells were depleted from 0.5–16108 tonsil MNC using
anti-human CD25 coated MACS microbeads (Miltenyi Biotec,
Surrey, UK) and magnetic cell sorting (MACS) on LD columns
(Miltenyi Biotec) according to the manufacturer’s instructions
[7,10]. Purity of depleted cells were typically .96% as assessed by
flow cytometry using APC-labeled anti-human CD25 antibody
(BD Bioscience, Oxford, UK). Approximately 4–10% of tonsil
CD4 T-cells were CD25hi. The removal of CD25hi cells has been
validated by our group and others as an experimental approach
that removes a population of regulatory cells [7,10,12].
Proliferation Assay
As previously [11], MNC were labeled with 2.5 mm carboxy-
fluorescein diacetate 5,6 succinimidyl ester (CFSE) dye (Invitrogen)
to identify dividing T cells. Labeled cells were cultured at 16106
cells/ml in a 48 well plate with either pneumoCCS (8 mg/ml), Ply-
CCS (8 mg/ml), influenza (0.9 mg/ml), MTB-PPD (10 mg/ml) or
media only, for 8 days. Cells were harvested and stained with anti-
CD4-APC (BD Biosciences) and assessed by flowcytometry. For
flowcytometric assays, 10,000–60,000 events were acquired on
either FACSCalibur (BD Biosciences, UK) or CyAnADP 9 Color
(Beckman Coulter, USA) flowcytometers. Analysis was performed
with FlowJo (TreeStar, Ashland, OR). In tonsil and peripheral
blood cultures CD4 T cell proliferation from media only was
subtracted from antigen-specific responses and then expressed as
the percentage of CD4+cells.
Statistics
Age related acquisition of naturally acquired immunity to upper
respiratory tract (URT) pathogens was modeled using non linear
regression and fitted with second order polynomial. The Spear-
mans rank test was used to determine the relationship between
mucosal and circulating antigen-specific T-cells. The Wilcoxon
signed rank test was used to test differences between undepleted
tonsillar MNC and CD25 depleted groups following antigenic
stimulation. All analysis was performed using Graphpad Prism5
software and p,0.05 was considered statistically significant.
Results
Mucosal Tonsillar and Peripheral Blood Pneumococcal-
specific CD4 T-cells are Present in Malawian Children
Early in Life
Recently we have shown robust CD4 T cell responses to
Streptococcus pneumoniae in peripheral blood of healthy Malawian
children [13] and adults [11], however, the kinetics of naturally
acquired immunity with age have not been described. Mucosal
tonsillar and peripheral blood CD4 T-cell proliferation was
evaluated in response to pneumococcal, influenza and MTB-
PPD antigens in children (age 1–12 years) and older children and
adults ($13–41). For analysis purposes these ages were chosen as
1–12 yrs is the age at which the highest rates of pneumococcal
colonization occur in an industrialized and resource poor setting
[14] before the decline in colonization seen in adulthood. In the
mucosal compartment, children had a broad range of pneumo-
coccal-specific tonsillar CD4 T cell responses that were greater in
the presence of the immunodominant antigen pneumolysin (WT
median 6.3[1.1–37] vs. ply- 3.4[0.5–33.1] (Fig.1a&b). WT
pneumococcal responses were greater as compared to influenza
(median 3.5[0–20.9] (Fig.1c) and MTB-PPD (median 2.6[0–24.9]
(Fig.1d)within the mucosa of children #12 years. In individuals
aged 13–41 yrs T-cell responses to all antigens were sustained
(WT median 6.9[0–19], ply- 3.7[0–24.7], influenza 5.6[0–31.2]
and MTB-PPD 1.5[0–20.2]). In the periphery, pneumococcal-
specific (Fig.1e, f) T-cells were present in the majority of children
early in life (WT median 7.6[0–41], ply- 4.8[0.1–24.8] at
a comparable level to the mucosa and once again were greater
than influenza-specific (Fig.1g) and MTB PPD responses (Fig.1h)
(influenza 3.7[0–30.4], MTB-PPD 2.7[0.4–62.1]). Whilst T cell
immunity to the pneumococcus decreased slightly in individuals
aged 13–41 yrs ((WT median 5.2[0–45.1], ply- 3.2[0–20.2])
responses to influenza and MTB-PPD increased with age (in-
fluenza 7.9[0–32.2], MTB-PPD 7.6[0–46.9]. In both children and
adults, high CD4 T-cell responses in peripheral blood did not
necessarily correlate with high responses within the mucosa. There
Regulation of Antigen-Specific T Cell Responses
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Figure 1. Mucosal and peripheral blood CD4 T cell responses to pneumococcal, influenza and MTB-PPD antigens in Malawian
children and adults. Mucosal CD4 T cell proliferation in response to pneumoCCS n=26 (a) and Ply-CCS n= 24 (b) influenza n = 25 (c) and MTB
n= 25 (d) in children and adults. Circulating CD4 T cell proliferation in response to pneumoCCS n= 66 (e), Ply-CCS n= 67 (f), influenza n = 65 (g) and
MTB-PPD n= 58 (h) in children and adults. Data was analyzed by nonlinear regression modeling, fitted with second order polynomial.
doi:10.1371/journal.pone.0051425.g001
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Figure 2. Inhibition of pneumococcal, influenza and MTB responses by regulatory T cells in young children and onwards. Mucosal
CD4 T cell responses to pneumoCCS (a) and PlyCCS (b) influenza (c) and MTB PPD (d) by CD25hi regulatory T cells in subjects above 3 years old as
indicated by increased cell proliferation following depletion of CD25hi cells from tonsillar MNC population. Subjects (n = 22) were grouped into those
aged 3–7 yrs, 8 to 17 yrs and.18 yrs. Individual subject’s proliferative response pre (circle) and post CD25hi cell depletion (square) are shown with
a connecting lines. Data was analyzed using Wilcoxon signed rank test, * = p,0.05. Representative flow cytometric plot of CD25 undepleted and
depleted tonsillar mononuclear cells (TMNC) (e).
doi:10.1371/journal.pone.0051425.g002
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was a positive correlation regarding the magnitude of influenza
responses in blood and tonsils r = 0.5, p = 0.02 but no correlation
for pneumococcal or MTB-PPD responses (data not shown).
Immune Regulation of Pneumococcal-specific CD4 T-cell
Responses in the URT Mucosa of Healthy Malawian
Children and Adults
Immune regulation is a common outcome for colonizing
bacteria [10]. In a setting of low colonization we and others have
shown that mucosal responses to pneumococcal proteins but not
influenza antigens are regulated by CD25hi cells in the majority of
UK adults [7,10] and in children [12]. We investigated whether
Tregs were generated in Malawian children following intense
pneumococcal exposure and whether immune modulation can
partly explain prolonged nasopharyngeal colonization and higher
incidence of IPD. For this study the age groups used were based on
previous work undertaken in an industrialised setting [7,12] so that
the frequency of mucosal regulation could be compared between
an area of low pneumococcal colonization vs high colonization. In
children aged 3–7 years, we find that 2 out of 8 had increased
tonsillar T-cell proliferation to pneumoCCS (Fig.2a) after re-
moving CD25hi cells. T-cell responses to Ply-CCS increased in 4 of
9 individuals (Fig.2b) influenza-specific responses increased in 6 of
9 individuals (Fig.2c) and 1 of 9 in response to MTB-PPD
(Fig.2d). In older children aged 8–17, we found a significant
increase in proliferative responses to Ply-, influenza and MTB-
PPD antigens, furthermore in those aged 8–17 and adults $18
years, immune regulation was present in $50% of those
responding to pneumococcal, influenza and MTB-PPD antigens
within the URT mucosal tonsillar tissue. Immune suppression was
not pneumolysin dependent as regulation was also observed in
pneumolysin-deficient cultures.
Discussion
In an African population with high pneumococcal carriage, we
find the majority of young children have high numbers of
pneumococcal-specific CD4 T-cells within the URT mucosa and
circulation. This contrasts with our observations in lower carriage
populations where the acquisition of pneumococcal immunity was
more gradual; where mucosal T-cells increased with age and
peaked aged 13–21 [7]. Furthermore, in comparison to UK
populations, we found far less compartmentalization of pneumo-
coccal and influenza-specific T-cells in mucosal tonsillar tissue
versus blood. This rapid acquisition of T-cell memory in this
African population appears to be associated with a higher degree
of regulation at an earlier age and to a broader range of pathogens
than seen in a UK population [7,10]. To what extent this
regulation is protective or maladaptive needs further investigation.
Mucosal immune regulation is a common outcome for other
colonizing bacteria [10]. Recently in a UK setting of low
pneumococcal colonization, we have shown that CD25hi cells
contain a regulatory population that suppress T-cell immunity to
S. pneumoniae [7] but not to the obligate pathogen influenza. In an
area of high colonization and pathogen exposure, we show that
depletion of CD25hi cells from tonsillar mononuclear cells
increased T-cell responses to all URT antigens, revealing the
proliferative capacity of an otherwise regulated population. It
could be argued that the removal of CD25hi cells depletes poorly
proliferative Tregs and enriches effector T cell proliferative
responses. However, we do not think this explains the increase
in T cell proliferation seen in our study as we would expect
a consistent increase in proliferative response following CD25hi
depletion in all ages and for all antigens in a setting of high antigen
exposure. Therefore, we propose that our data shows that immune
regulation to URT pathogens is more common and broad in
Malawian children #17 years, with 50% and 56% of individuals
showing regulation of pneumococcal and influenza-specific
responses respectively, compared to 25% and 18% of children
from the UK. The observation that some individuals show
immune regulation whilst others do not is expected in human
studies, however this variation may be influenced by the duration
and density of the latest pneumococcal carriage event. Contrary to
our expectations we observed comparable pneumococcal, in-
fluenza and MTB-PPD CD4 T-cells in both the mucosa and
circulation of Malawian adults, showing no distinct compartmen-
talization of immune responses to URT pathogens. These findings
suggest that high antigen exposure in the URT results in the
spillover and recirculation of antigen-specific T-cells that are easily
detected in blood. These differences are likely to be driven by the
frequency and perhaps density of antigen exposure, in Malawian
adults rates of pneumococcal colonization are between 16–20%,
whilst the UK is #10%.
We show that pneumococcal responses at the mucosal surface
are highly regulated in African children; over-regulation may
prolong colonization, increase the chance of person-to-person
spread and delay herd immunity. Whilst capsular polysaccharide-
protein conjugate vaccines (PCV) are effective in reducing
colonization and invasive pneumococcal disease of vaccine
serotypes, they are less effective in preventing mucosal disease
(pneumonia or otitis media) [15]. Also in vulnerable HIV
populations, PCV7 was shown to reduce recurrent IPD but
immune protection was short-lived [16]. Several pneumococcal
surface-expressed proteins, including pneumolysin have been
identified as potential vaccine candidates that could compliment
the capsular polysaccharide approach. We believe that defining
natural mucosal immunity to the pneumococcus is important for
the future evaluation of pneumococcal vaccine induced immunity
within the mucosal compartment. Recently parenteral meningo-
coccal B vaccination was shown to reprogram pre-existing
antigen-specific mucosal responses [17]. Changes in the mucosal
Th1/Th2 balance and increased mucosal IL-10 secretion revealed
in the study highlight a need for caution when applying parental
protein-vaccines to the prevention of disease caused by URT
commensals. This is an important consideration when vaccinating
HIV-infected individuals as regulatory T-cells are frequently over-
represented in the periphery [11], the same may be true within the
URT mucosa. As immune dysregulation occurs in many sub-
Saharan vulnerable populations [8] we propose that new protein
vaccine candidates are screened to reduce the chance of further
immunomodulation of pneumococcal responses.
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